The next continued petition for consideration today is PE1723, on essential tremor treatment, which has been lodged by Mary Ramsay. I welcome Rhoda Grant MSP, who is attending for our consideration of the petition.
We last considered PE1723 in September 2019, when we agreed to write to the Scottish Government and Dr Gilbertson of NHS Tayside, and to delegate authority to the clerks to write to other relevant stakeholders. Responses have been received from the Scottish Government, NHS Tayside, Sue Ryder, the National Tremor Foundation and the petitioner.
NHS Tayside notes that magnetic resonance-guided focused ultrasound—MRgFUS—is a technology that has significant potential as a treatment for patients who suffer from essential tremor and Parkinson’s disease. NHS Tayside is in the advanced stages of achieving its fundraising target for acquisition and installation of MRgFUS equipment.
The Scottish Government submission notes that the national specialist services committee met on 4 December 2018 to consider a stage 1 application for specialist treatment of patients with essential tremor using MRgFUS. The committee was unable to endorse the application for funding as a nationally designated service. It was highlighted that National Institute for Health and Care Excellence guidance is permissive, and that although there is some evidence for use of MRgFUS in essential tremor treatment, there is a clear statement that research is needed into its application for Parkinson’s disease and multiple sclerosis tremor.
I ask Rhoda Grant to contribute before further discussion.